ATAC DDC Liaisons: Ken Fornataro & Nita Costello

CONTACT INFORMATION

Michael N. Joyner
Manager, HIV Patient Advocacy Relations
GlaxoSmithKline
P. O. Box 13398
Research Triangle Park, NC 27709

E-mail: [email protected]
Telephone: (919) 483-2987
Fax: (919) 315-0062

PRODUCT INFORMATION

1. FDA-Approved Products:
   • Nucleoside analogue reverse transcriptase inhibitors:
     • abacavir (Ziagen®)
     • lamivudine (Epivir® 3TC)
     • zidovudine (Retrovir&areg; AZT, ZDV)
     • zidovudine/lamivudine (Combivir®)
     • zidovudine/lamivudine/abacavir (Trizivir®)
     • abacavir/lamivudine (Epzicom®)
   • Protease inhibitor:
     • fosamprenavir (Lexiva®)
     • amprenavir (Agenerase®)
2. Products in Clinical Trials:
   • Integrase inhibitor
   • Protease inhibitor 

Web pages:

• GlaxoSmithKline http://www.gsk.com/
• TreatHIV.com http://www.treathiv.com/ (has sub-pages for individual products)